User:Irvindfisherk

From AnnodexFoundation

Jump to: navigation, search



($ in millions, except antibiotics acyclovir for the circumcised per share amounts)



Fourth-Quarter





Full-Year




2008





2007





Change




2008




antibiotics 
2007





Change


Reported naproxen cosmetics cosmetic herpes treatment Revenues


$ 12,346
valacyclovir 



$ 12,870




(4%)



amoxycillin 
$ 48,296




$ 48,418




--


Reported Net Income
aciclovir 

266




2,724




(90%)



does ramipril cause hair to thin 
8,104




8,144




tetracycline --


Reported Diluted EPS


0.04




0.40
genital herpes 



(90%)




1.20



herpes treatment rx antibiotic eye drop 
1.17




3%


Adjusted Revenues(1)

12,311




12,795

azithromycin azythromycin 


(4%)




48,341


tetracycline com games game 

48,209




--


Adjusted Income(1)

4,389




3,402
drugstore can acai be used with cipralex 



29%




16,366




15,113




8%


Adjusted Diluted EPS(1)

0.65




0.50




30%




2.42




2.18




11%



prescription drugs 
























See end amoxicillin and potassium whey and orlistat clavulanate of text prior to tables for notes. 

PFE - News) today reported financial results best online pharmacy school for

fourth-quarter and full-year 2008. This decrease was primarily attributable to 
the negative promethazine suppository impact of the loss of U.S. Zyrtec, Camptosar and Norvasc fourth-quarter 2008 
revenues decreased by $515 million ($263 million, is tumeric safe to take with synthroid i $144 million and $108 
million, respectively), compared. For fourth-quarter 2008, the citrus dairy metformin Company 
recorded reported revenues of $12.3 billion, a decrease of 4% compared 
with the year-ago quarter. Exclusivity for Zyrtec in 
and for Camptosar in as well as the loss of 
exclusivity for Norvasc in Korea and Japan in and July 
2008, respectively.
Personal tools